Indivior logo

INDV - Indivior News Story

165p 6.5  4.1%

Last Trade - 30/07/21

Market Cap £1.16bn
Enterprise Value £689.8m
Revenue £482.8m
Position in Universe 407th / 1800

Indivior looks beyond opioid-addiction treatments with new deal

Tue 8th June, 2021 1:07pm
June 8 (Reuters) - Opioid-addiction treatment maker Indivior
 INDV.L  said on Tuesday it was expanding into possible
treatments for cannabis-related disorders through an agreement
with a French privately held company.
    London-listed Indivior has agreed to pay Aelis Farma $30
million upfront under the agreement to work exclusively on an
experimental drug which blocks a type of cannabinoid receptor.
(https://refini.tv/3g3MREA)

 (Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak
Dasgupta)
 ((Pushkala.A@thomsonreuters.com; Twitter: @pullthekart; Mobile:
+91 852 751 3793))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.